Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ciaramella, Antonio ^a   Salani, Francesca ^a   Bizzoni, Federica ^a   Pontieri, Francesco E ^b   Stefani, Alessandro ^c   Pierantozzi, Mariangela ^c   Assogna, Francesca ^a   Caltagirone, Carlo ^a   Spalletta, Gianfranco ^a   Bossù, Paola ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD ANALYSIS; CASE CONTROL STUDY; CELL COUNT; CELL TRANSPORT; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HOEHN AND YAHR SCALE; HUMAN; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MYELOID DENDRITIC CELL; PARKINSON DISEASE; PLASMACYTOID DENDRITIC CELL; UNIFIED PARKINSON DISEASE RATING SCALE;

CASE-CONTROL STUDIES; DENDRITIC CELLS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84878937679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065352     Document Type: Article

References (34)

1. Hirsch EC, Hunot S, (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8: 382-397.
2. Reynolds AD, Stone DK, Mosley RL, Gendelman HE, (2009) Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J Immunol 182: 4137-4149.
3. Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, et al. (2003) Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J 17: 500-502.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
5. Mabbott NA, Mackay F, Minns F, Bruce ME, (2000) Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6: 719-720.
6. Ciaramella A, Bizzoni F, Salani F, Vanni D, Spalletta G, et al. (2010) Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease. J Alzheimers Dis 19: 559-572.
7. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, et al. (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11: 328-334.
8. Yilmaz A, Fuchs T, Dietel B, Altendorf R, Cicha I, et al. (2009) Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clin Sci 118: 147-157.
9. Liu YJ, (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259-262.
10. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, et al. (2007) Dendritic cell subsets in health and disease. Immunol Rev 219: 118-142.
11. Hughes AJ, Daniel SE, Lees AJ, (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57: 1497-1499.
12. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC.
13. Folstein MF, Folstein SE, McHugh PR, (1975) The Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 2: 189-198.
14. Beck A, Steer RA (1987) Beck Depression Inventory Manual. San Antonio, TX, The Psychological Corporation.
15. Fahn S, Elton RL (1987) Unified Parkinson's Disease Rating Scale. In: Fahn D, Marsden PD, Calne DB, Liebarman A, editors. Recent Development in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information. 153-163.
16. Hoehn MM, Yahr MD, (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
17. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
18. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, et al. (1997) Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 94: 12551-12556.
19. Liu YJ, (2005) IPC: professional type 1 interferon producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
20. Pacheco R, Prado CE, Barrientos MJ, Bernales S, (2009) Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 216: 8-19.
21. Prado C, Contreras F, González H, Díaz P, Elgueta D, et al. (2012) Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol 188: 3062-3070.
22. Garbe K, Bratke K, Wagner S, Virchow JC, Lommatzsch M, (2012) Plasmacytoid dendritic cells and their Toll-like receptor 9 expression selectively decrease with age. Hum Immunol 73: 493-497.
23. Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A, (2002) Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 36: 734-741.
24. Dillon SM, Robertson KB, Pan SC, Mawhinney S, Meditz AL, et al. (2008) Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 48: 1-12.
25. Uehira K, Amakawa R, Ito T, Tajima K, Naitoh S, et al. (2002) Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 105: 296-303.
26. Koutsilieri E, Lutz MB, Scheller C, (2013) Autoimmunity, dendritic cells and relevance for Parkinson's disease. J Neural Transm 120: 75-81.
27. Oberländer U, Pletinckx K, Döhler A, Müller N, Lutz MB, et al. (2011) Neuromelanin is an immune stimulator for dendritic cells in vitro. BMC Neurosci 12: 116.
28. Iribarren P, Cui YH, Le Y, Wang JM, (2002) The role of dendritic cells in neurodegenerative diseases. Arch Immunol Ther Exp 50: 187-196.
29. Rezai-Zadeh K, Gate D, Town T, (2009) CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease? J Neuroimmune Pharmacol 4: 462-475.
30. Funk N, Wieghofer P, Grimm S, Schaefer R, Bühring HJ, et al. (2013) Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease. Mov Disord. 28: 392-5.
31. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, et al. (2010) The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease. Psychosomatics 51: 474-479.
32. Barnum CJ, Tansey MG, (2012) Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? Curr Neurol Neurosci Rep 12: 350-358.
33. Gotham AM, Brown RG, Marsden CD, (1986) Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381-389.
34. Anderson G, Maes M, Berk M, (2012) Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome. Med Hypotheses 78: 752-756.